- Home
- YDDL vs MNPR Comparison
YDDL vs MNPR Comparison
Compare YDDL & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YDDL | MNPR |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | Philippines | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 358.9M | 368.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | YDDL | MNPR |
|---|---|---|
| Price | $15.34 | $53.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $107.00 |
| AVG Volume (30 Days) | ★ 304.7K | 167.6K |
| Earning Date | 05-25-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.99 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $40.85 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.61 | $26.06 |
| 52 Week High | $15.90 | $105.00 |
Technical Indicators
Market Signals| Indicator | YDDL | MNPR |
|---|---|---|
| Relative Strength Index (RSI) | 71.60 | 40.55 |
| Support Level | $4.77 | $50.92 |
| Resistance Level | $15.90 | $62.49 |
| Average True Range (ATR) | 1.94 | 4.29 |
| MACD | 0.35 | -0.16 |
| Stochastic Oscillator | 89.67 | 14.75 |
Price Performance
Historical ComparisonAbout YDDL One and One Green Technologies. Inc Class A Ordinary Shares
One and one Green Technologies Inc is engaged in recycling, production, and trading of recycled scrap metals in the Republic of Philippines. The company process raw materials and generate final products that include copper alloy ingot, aluminum scrapes, plastic beads, and others. It provides economical and flexible solutions to the challenges of electronic waste, metal scrap and industrial recycling. By providing lower-cost alternatives for processing recycled materials, It is not only Contributing to environmental sustainability but also highlight its role as a modern and specialized recycling company.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.